SCHEMBL6237729

SCHEMBL6237729

CC(C)(NC(=O)Nc1ccc(Cl)cc1)C(=O)Nc1ccc(-c2ccccc2S(C)(=O)=O)cc1F

nearest known ligand 0.62

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
F10 P00742 13/20 0.62
FPR2 P25090 7/20 0.48
FPR1 P21462 5/20 0.48
F2 P00734 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6244644 0.92 F10 (0.60) F10F2
SCHEMBL6839561 0.88 F10 (0.57) F10FPR2FPR1F2
SCHEMBL6240809 0.87 F10 (0.49) F10FPR2FPR1F2
SCHEMBL6841157 0.86 F10 (0.57) F10FPR2FPR1F2
SCHEMBL6239904 0.83 F10 (0.64) F10FPR2FPR1F2
SCHEMBL6838432 0.81 F10 (0.48) F10F2
SCHEMBL6261678 0.80 F10 (0.57) F10F2
SCHEMBL6241390 0.78 F10 (0.75) F10FPR2FPR1F2
SCHEMBL6839419 0.77 F10 (0.78) F10FPR2FPR1F2
SCHEMBL6838895 0.77 F10 (0.59) F10FPR2FPR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040167131-A1 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade PFIZER INC. 2004-08-26 US claimed
EP-1539686-A1 INHIBITORS OF FACTOR XA AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION CASCADE WARNER-LAMBERT COMPANY LLC (US) 2005-06-15 EP disclosed
US-20040167131-A1 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade PFIZER INC. 2004-08-26 US disclosed
WO-2004024679-A1 INHIBITORS OF FACTOR XA AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION CASCADE WARNER-LAMBERT COMPANY LLC (US) 2004-03-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040167131-A1 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade TFPI, SERPINC1, F11 F10 13/4885FPR2 1122/4885FPR1 582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.